EUVIMED · CrossrefZeitschrift
IJTLD Open
ISSN 3005-7590 · International Union Against Tuberculosis and Lung Disease
Neueste Artikel
Utility of stool culture for the diagnosis and management of paediatric TB in a low-burden setting
Comprehensive care lowers multimorbidity, impairment, disability and absenteeism in people with TB
Sustained outcomes 3 years after all-oral 9-month regimen for rifampicin-resistant TB
Fifteen years of rifampicin-resistant TB control in Niger: high countrywide treatment uptake and success
Culturally relevant settings for TB transmission in an African city with endemic TB
Decentralising drug-resistant TB treatment initiation services
Proceedings from the Third International Post-Tuberculosis Symposium: expanding the circle
High loss to follow-up on a bedaquiline-based regimen for rifampicin-resistant TB
Low-level BTZ-043 resistance in Mycobacterium tuberculosis and cross-resistance to bedaquiline and clofazimine
Global child-friendly anti-TB medicines – where do we stand?
Progress and challenges to TB elimination in New South Wales, Australia
Adolescents and young adults with TB in a low-incidence setting
Antenatal screening for TB disease: a systematic review and meta-analysis
Treatment success rate and time to culture conversion under a prospective BPaL cohort study
Children’s preferences among six novel moxifloxacin and linezolid-dispersible tablet formulations
Impact of US funding cuts and stop work orders on TB services and research in South Africa
Treatment outcomes of pulmonary TB in adults in Indonesia
Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatment
The Western Pacific Regional Framework to End TB: overview and critical reflection
Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes
Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency
Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan
Timing of recurrence after treatment of pulmonary TB
Stool Xpert ® MTB/RIF Ultra for TB diagnosis in children: experience from a national scale-up programme
Rethinking latent TB? Think again
TB prevention activities in the WHO European Region
Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
Management challenges and outcomes for non-tuberculous mycobacterial pulmonary disease
Severe outcomes among adults with TB during COVID-19
TB preventive therapy: uptake and time to initiation during implementation of ‘7-1-7’
EUVIMED